Completed PHASE4 INTERVENTIONAL 3-arm NCT00935688

Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area

An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species

Sponsor: Health Protection and Research Organisation

Conditions Fever Malaria

Interventions Rapid diagnostic test

Updated 6 times since 2017 Last updated: Feb 6, 2014 Started: May 31, 2009 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Fever and Malaria and is currently completed. Health Protection and Research Organisation leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Health Protection and Research Organisation
HealthNet TPO
London School of Hygiene and Tropical Medicine
Medical Emergency Relief International (Merlin)

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jalalabad, Afghanistan
• Kunduz, Afghanistan